These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 18669010

  • 1. Are CSN and NKF-K/DOQI mineral metabolism guidelines for hemodialysis patients achievable? Results from a provincial renal program.
    Wazny LD, Raymond CB, Lesperance EM, Bernstein KN.
    CANNT J; 2008; 18(2):36-41, 44-50; quiz 42-3, 51-2. PubMed ID: 18669010
    [Abstract] [Full Text] [Related]

  • 2. Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units.
    Arenas MD, Alvarez-Ude F, Gil MT, Soriano A, Egea JJ, Millán I, Amoedo ML, Muray S, Carretón MA.
    Nephrol Dial Transplant; 2006 Jun; 21(6):1663-8. PubMed ID: 16464885
    [Abstract] [Full Text] [Related]

  • 3. Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia.
    Maduell F, Gorriz JL, Pallardo LM, Pons R, Santiago C, Multicentric group for the study of the phosphocalcic metabolism in the community of Valencia.
    J Nephrol; 2005 Jun; 18(6):739-48. PubMed ID: 16358233
    [Abstract] [Full Text] [Related]

  • 4. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
    Craver L, Marco MP, Martínez I, Rue M, Borràs M, Martín ML, Sarró F, Valdivielso JM, Fernández E.
    Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
    [Abstract] [Full Text] [Related]

  • 5. Prevalence, clinical correlates and therapy cost of mineral abnormalities among haemodialysis patients: a cross-sectional multicentre study.
    Lorenzo V, Martin-Malo A, Perez-Garcia R, Torregrosa JV, Vega N, de Francisco AL, Cases A.
    Nephrol Dial Transplant; 2006 Feb; 21(2):459-65. PubMed ID: 16263739
    [Abstract] [Full Text] [Related]

  • 6. Early initiation of cinacalcet for the treatment of secondary hyperparathyroidism in hemodialysis patients: a three-year clinical experience.
    Lucchi L, Carboni C, Stipo L, Malaguti V, Ferrari F, Graziani R, Arletti S, Graziosi C.
    Artif Organs; 2011 Dec; 35(12):1186-93. PubMed ID: 21848793
    [Abstract] [Full Text] [Related]

  • 7. Adherence to K/DOQI practice guidelines for bone metabolism and disease.
    Hoy T, Fisher M, Barber B, Borker R, Stolshek B, Goodman W.
    Am J Manag Care; 2007 Nov; 13(11):620-5. PubMed ID: 17988187
    [Abstract] [Full Text] [Related]

  • 8. K/DOQI guidelines for bone metabolism and disease in chronic kidney disease patients: some therapeutic implications.
    Uribarri J, National Kidney Foundation.
    Semin Dial; 2004 Nov; 17(5):349-50. PubMed ID: 15461740
    [Abstract] [Full Text] [Related]

  • 9. Management of calcium and phosphorus metabolism in hemodialysis patients in Tehran Province, Iran.
    Mahdavi-Mazdeh M, Zamyadi M, Norouzi S, Heidary Rouchi A.
    Iran J Kidney Dis; 2007 Jul; 1(1):25-8. PubMed ID: 19357440
    [Abstract] [Full Text] [Related]

  • 10. Adherence to K/DOQI guidelines for calcium-based phosphate binders in clinical practice.
    Shastri J, Tran A, Covit A, Pepe J, Sherman RA.
    J Ren Nutr; 2008 Jul; 18(4):370-4. PubMed ID: 18558302
    [Abstract] [Full Text] [Related]

  • 11. Development and utility of a multi-dimensional grid to assess individual mineral metabolism control in hemodialysis patients: A potential aid for therapeutic decision making?
    Morton AR, Murphy S, Hirsch D, Leblanc M, Barré P, Lok C, Hercz G, Hodsman A, Reslerova M, Levin A.
    Hemodial Int; 2010 Apr; 14(2):200-10. PubMed ID: 20337745
    [Abstract] [Full Text] [Related]

  • 12. Adherence to mineral and bone disorder clinical practice guidelines in chronic kidney disease.
    Panawong W, Chaiyakum A, Pongskul C.
    J Med Assoc Thai; 2011 Oct; 94(10):1175-83. PubMed ID: 22145501
    [Abstract] [Full Text] [Related]

  • 13. Quality of care assessment and adherence to the international guidelines considering dialysis, water treatment, and protection against transmission of infections in university hospital-based dialysis units in Cairo, Egypt.
    Ibrahim S.
    Hemodial Int; 2010 Jan; 14(1):61-7. PubMed ID: 19758297
    [Abstract] [Full Text] [Related]

  • 14. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
    Mazzaferro S, Pasquali M, Farcomeni A, Vestri AR, Filippini A, Romani AM, Barresi G, Pugliese F.
    Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
    [Abstract] [Full Text] [Related]

  • 15. Impact of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Bone Metabolism and Disease in a large dialysis network.
    Wald R, Tentori F, Tighiouart H, Zager PG, Miskulin DC.
    Am J Kidney Dis; 2007 Feb; 49(2):257-66. PubMed ID: 17261428
    [Abstract] [Full Text] [Related]

  • 16. Mineral metabolism and mortality in dialysis patients: a reassessment of the K/DOQI guideline.
    Noordzij M, Korevaar JC, Dekker FW, Boeschoten EW, Bos WJ, Krediet RT, Bossuyt PM, Geskus RB, NECOSAD study group.
    Blood Purif; 2008 Feb; 26(3):231-7. PubMed ID: 18305386
    [Abstract] [Full Text] [Related]

  • 17. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL, Robinson BM, Port FK.
    Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
    [Abstract] [Full Text] [Related]

  • 18. Interprovincial differences in the achievement of K/DOQI targets of mineral metabolism in Canada.
    Lebner AC, Beard KM, Soroka SD, Cournoyer SH, Da Roza GA, Geary DF, Mendelssohn DC.
    Nephrol Dial Transplant; 2011 Jan; 26(1):156-63. PubMed ID: 20667990
    [Abstract] [Full Text] [Related]

  • 19. Achievement of the Japanese Society for Dialysis Therapy guideline targets for mineral metabolism measures: one Japanese university center result.
    Kimata N, Miwa N, Otsubo S, Iwasaki T, Yabuki Y, Miyabe K, Asamiya Y, Sato K, Sugi O, Ikebe N, Kiuchi K, Mineshima M, Akiba T.
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S62-6. PubMed ID: 17976088
    [Abstract] [Full Text] [Related]

  • 20. [CA-P control in haemodialysis and K/DOQI guidelines].
    Rivera F, Sánchez de la Nieta MD, Echarri R, Anaya S, Carreño A, Vozmediano MC, Alcaide MP.
    Nefrologia; 2006 Oct; 26(3):351-7. PubMed ID: 16892824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.